BioSpace News Archive

Policy

EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies

Under the European Union’s proposed regulations, companies will have data protection for at least seven-and-a-half years preventing competitors from accessing their product data.

March 20, 2024
·
2 min read
·
Tristan Manalac
Career Advice

New Graduates Struggle in Current Biopharma Job Market

A string of rejections prompt some to look beyond research roles in the biopharma industry as they seek to launch a career.

March 20, 2024
·
3 min read
·
Aayushi Pratap
Job Trends

Top 5 Remote Quality-Control Jobs

Looking for remote quality-control jobs in the life sciences industry? Check out this BioSpace list of five top jobs that are remote.

March 20, 2024
·
1 min read
·
Angela Gabriel
Career Advice

How to Talk About Politics at Work

Politics can be a touchy subject, especially during a presidential election year. How should you engage in political discussions at work?

March 20, 2024
·
4 min read
·
Angela Gabriel
FDA

Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label

Takeda on Tuesday secured another label expansion for the kinase inhibitor, this time in the first-line setting for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

March 20, 2024
·
2 min read
·
Tristan Manalac
Deals

Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B

The contract manufacturer plans to expand its U.S. footprint with a former Roche facility in Vacaville, California, which Lonza contends is one of the largest biologics manufacturing facilities in the world by volume.

March 20, 2024
·
1 min read
·
Tyler Patchen
Policy

What Another Trump Presidency Could Mean for Big Pharma

President Joe Biden has made drug pricing a cornerstone of his campaign, but former President Donald Trump also plans to target drugmakers if he reenters the White House.

March 20, 2024
·
5 min read
·
Tyler Patchen
Drug Development

Novo Invests $556M in China Operations to Boost Manufacturing Capacity

Novo Nordisk’s investment of more than half a billion dollars is meant to expand its production capabilities in China and help it meet the global drug demand.

March 20, 2024
·
2 min read
·
Tristan Manalac
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers

Clasp Therapeutics announced Wednesday that the Series A funding, which was led in part by Novo Holdings, will support development of its T cell engagers for highly specific tumor targeting.

March 20, 2024
·
2 min read
·
Kate Goodwin
Drug Delivery

Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval

Two days after winning FDA approval, Orchard Therapeutics on Wednesday provided its U.S. launch plans for metachromatic leukodystrophy gene therapy Lenmeldy, which has a wholesale acquisition cost of $4.25 million for the one-time treatment.

March 20, 2024
·
2 min read
·
Tristan Manalac